semaglutide chinese Christian Schmollinger: China's first biosimilar Ozempic drug applies for approval, ETHealthworld Chinese biotech targets 2028 trial

BMI Is GLP-1 right for me?* 24.9 or less No 25.0 29.9 Case-by-case 30.0 or above Likely *The above chart is not meant for medical diagnosis purposes

That glucagon component is the key differentiator, it increases energy expenditure rather than relying on appetite suppression alone

What is it about bacon that is so alluring

Newsweek discussed the potential rapid weight gain for patients who stop taking Ozempic with two experts.

PatchMD unveiled its new GLP-1 Support Patch Collection, designed to provide essential support for individuals using GLP-1 receptor against..

GLP-1 receptor agonists (GLP-1RAs), initially approved for diabetes and obesity, are now under investigation for neuroprotective effects in a range of neurological disorders